Case number 2016-1308
Amgen Inc. v. Apotex Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | AMGEN INC. v. APOTEX INC. [OPINION] [precedential] (0) |
| Apr 23, 2021 | 0 | AMGEN INC. v. APOTEX INC. [ERRATA] [precedential] (0) |
| Dec 13, 2016 | 105 | The petition for writ of certiorari, [16-332], filed on 09/09/2016, was Denied on 12/12/2016. [390467] [FMS] [Entered: 12/13/2016 11:53 AM] (1) |
| Sep 16, 2016 | 104 | Petition for writ of Certiorari filed on 09/09/2016, placed on the docket 09/14/2016, in the Supreme Court of the United States. Supreme Court #: 16-332, Apotex Inc. v. Amgen Inc. [366973] [SJ] [Entered: 09/16/2016 11:56 AM] (1) |
| Aug 11, 2016 | 103 | Mandate issued to the United States District Court for the Southern District of Florida. Service as of this date by Clerk of Court. [357977] [LN] [Entered: 08/11/2016 10:10 AM] (1) |
| Jul 11, 2016 | 102 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: Notice regarding the ECF account of Allen P. Pegg, Esq. for Amgen Manufacturing Limited and Amgen Inc. The e-mail address, (julia.maganini@hoganlovells.com), associated with your CM/ECF account has generated a delivery failure notice. Pursuant to Fed. Cir. R. 47.3(c)(1), counsel should promptly update his account information with the Pacer Service Center. [349605] [IW] [Entered: 07/11/2016 08:24 AM] (0) |
| Jul 6, 2016 | 101 | ERRATA to the Precedential Opinion Doc No.: [100]. Service as of this date by Clerk of Court. [348927] [LN] [Entered: 07/06/2016 04:10 PM] (1) |
| Jul 5, 2016 | 100 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (Precedential Opinion). (For the Court: Wallach,Circuit Judge; Bryson,Circuit Judge and Taranto,Circuit Judge). [348253] [LN] [Entered: 07/05/2016 09:06 AM] (28) |
| Apr 4, 2016 | 99 | Submitted after ORAL ARGUMENT by Mr. Kerry Brendan McTigue for Apotex Inc. and Apotex Corp. and Nicholas P. Groombridge for Amgen Manufacturing Limited and Amgen Inc.. Panel: Judge: Wallach , Judge: Bryson , Judge: Taranto. [323505] [LAJ] [Entered: 04/04/2016 10:43 AM] (0) |
| Mar 9, 2016 | 98 | Notice to counsel for Amicus Curiae Janssen Biotech, Inc.: The record of this case indicates that the paper copies of amicus brief (see ECF-10(B)) and a separate certificate of interest have not been filed. A completed certificate of Interest must be submitted in accordance with Fed. Cir. R. 47.4 by 03/10/2016. The paper copies of the brief should be received by the court on or before 03/16/2016. Service as of this date by Clerk of Court. [317111] [LN] [Entered: 03/09/2016 11:50 AM] (0) |
| Feb 29, 2016 | 97 | Response to oral argument order from the Appellants Apotex Corp. and Apotex Inc.. designating Kerry B. McTigue as arguing attorney. Designated time for argument: 12 minutes. Designated time for rebuttal: 3 minutes. Service of other counsel by Notice of Docket Activity from this entry. [314527] [Kerry McTigue] [Entered: 02/29/2016 01:23 PM] (0) |
| Feb 23, 2016 | 96 | Response to oral argument order from the Appellees Amgen Inc. and Amgen Manufacturing Limited. designating Nicholas Groombridge as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [313318] [Nicholas Groombridge] [Entered: 02/23/2016 02:26 PM] (0) |
| Feb 19, 2016 | 95 | NOTICE OF CALENDARING. Panel: 1604B. Case scheduled Apr 04, 2016 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 402. Response to oral argument order due: 03/15/2016. Counsel should check-in 30 minutes prior to the opening of the session. Please review the Oral Argument Order. [312508] THIS NOTICE APPLIES TO CASE(S): [15-1824, 15-1844, 15-1859, 16-1308] [JAB] [Entered: 02/19/2016 03:33 PM] (0) |
| Feb 18, 2016 | 93 | 6 paper copies of the amicus Brief [87] received from Amicus Curiae Janssen Biotech, Inc.. [312089] [LAJ] [Entered: 02/18/2016 01:55 PM] (0) |
| Feb 18, 2016 | 94 | Entry of appearance for Andrew C. Nichols as of counsel for Amici Curiae Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc.. Service: 02/18/2016 by email. [312205] [Andrew Nichols] [Entered: 02/18/2016 05:04 PM] (5) |
| Feb 17, 2016 | 89 | 6 paper copies of the Reply Brief [84] received from Appellants Apotex Corp. and Apotex Inc.. [311749] [LAJ] [Entered: 02/17/2016 01:44 PM] (0) |
| Feb 17, 2016 | 90 | 6 paper copies of the appendix Brief [85] received from Appellants Apotex Corp. and Apotex Inc.. [311750] [LAJ] [Entered: 02/17/2016 01:45 PM] (0) |
| Feb 17, 2016 | 91 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a), Fed. Cir. R. 47.3 and ECF-2(E) to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal [Attorney William Blake Coblentz's EOA information does not match ECF Filer information]. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [311767] [LN] [Entered: 02/17/2016 02:11 PM] (0) |
| Feb 17, 2016 | 92 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a), Fed. Cir. R. 47.3 and ECF-2(E) to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal [EOA information for Andrew C. Nichols does not match ECF filer information]. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [311774] [LN] [Entered: 02/17/2016 02:20 PM] (0) |
| Feb 16, 2016 | 86 | 6 paper copies of the amicus Brief [78] received from Amicus Curiae Biotechnology Innovation Organization. [311183] [LAJ] [Entered: 02/16/2016 12:59 PM] (0) |
| Feb 16, 2016 | 88 | Entry of appearance for Stephen A. Maniscalco as of counsel for Appellees Amgen Inc. and Amgen Manufacturing Limited. Service: 02/16/2016 by email. [311447] [Nicholas Groombridge] [Entered: 02/16/2016 04:34 PM] (2) |
| Feb 12, 2016 | 77 | Entry of appearance for Daniel O'Boyle as of counsel for Biotechnology Innovation Organization. Service: 02/12/2016 by email. [310631] [Daniel O'Boyle] [Entered: 02/12/2016 09:44 AM] (2) |
| Feb 12, 2016 | 79 | Clerk's Note to the File: The certificate of interest for Biotechnology Innovation Organization is due on 2/26/16. [310643] [JCA] [Entered: 02/12/2016 09:58 AM] (0) |
| Feb 12, 2016 | 80 | Statement of Compliance with Fed. Cir. R. 33 for Appellants Apotex Corp., Apotex Inc. and Appellees Amgen Inc. and Amgen Manufacturing Limited. Service: 02/12/2016 by email. [310661] [Kerry McTigue] [Entered: 02/12/2016 10:53 AM] (3) |
| Feb 12, 2016 | 81 | Certificate of Interest for the Amicus Curiae Biotechnology Innovation Organization. Service: 02/12/2016 by email. [310719] [Lisa Pensabene] [Entered: 02/12/2016 12:12 PM] (3) |
| Feb 12, 2016 | 82 | TENDERED from Appellants Apotex Corp. and Apotex Inc.. Title: REPLY BRIEF. Service: 02/12/2016 by email. [310866] [Kerry McTigue] [Entered: 02/12/2016 04:36 PM] (31) |
| Feb 12, 2016 | 83 | TENDERED from Appellants Apotex Corp., Apotex Inc. and Appellees Amgen Inc. and Amgen Manufacturing Limited. Title: JOINT APPENDIX. Service: 02/12/2016 by email. [310874] [Kerry McTigue] [Entered: 02/12/2016 04:53 PM] (226) |
| Feb 12, 2016 | 84 | REPLY BRIEF FILED for Appellants Apotex Corp. and Apotex Inc. [82]. Number of Pages: 24. Service: 02/12/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 02/22/2016. [311045] [JCA] [Entered: 02/16/2016 10:11 AM] (30) |
| Feb 12, 2016 | 85 | APPENDIX FILED for Apotex Corp. and Apotex Inc. [83]. Number of Pages: 226. Service: 02/12/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the appendix should be received by the court on or before 02/22/2016. [311072] [JCA] [Entered: 02/16/2016 10:40 AM] (226) |
| Feb 11, 2016 | 72 | TENDERED from Janssen Biotech, Inc. Title: AMICUS CURIAE BRIEF. Service: 02/11/2016 by email. [310515] [Gregory Diskant] [Entered: 02/11/2016 04:38 PM] (38) |
| Feb 11, 2016 | 73 | Entry of appearance for Lisa B. Pensabene as principal counsel for Biotechnology Innovation Organization. Service: 02/11/2016 by email. [310535] [Lisa Pensabene] [Entered: 02/11/2016 06:27 PM] (2) |
| Feb 11, 2016 | 74 | TENDERED from Biotechnology Innovation Organization Title: AMICUS CURIAE BRIEF. Service: 02/11/2016 by email. [310537] [Lisa Pensabene] [Entered: 02/11/2016 06:40 PM] (31) |
| Feb 11, 2016 | 75 | Entry of appearance for Deanna M. Rice as of counsel for Biotechnology Innovation Organization. Service: 02/11/2016 by email. [310541] [Deanna Rice] [Entered: 02/11/2016 06:45 PM] (2) |
| Feb 11, 2016 | 76 | Entry of appearance for Filko Prugo as of counsel for Biotechnology Innovation Organization. Service: 02/11/2016 by email. [310543] [Filko Prugo] [Entered: 02/11/2016 06:47 PM] (2) |
| Feb 11, 2016 | 78 | AMICUS BRIEF FILED for Biotechnology Innovation Organization [74]. Number of Pages: 22. Service: 02/11/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 02/17/2016. [310642] [JCA] [Entered: 02/12/2016 09:56 AM] (31) |
| Feb 11, 2016 | 87 | AMICUS BRIEF FILED for Janssen Biotech, Inc. [72]. Number of Pages: 30. Service: 02/11/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 02/22/2016. [311224] [LN] [Entered: 02/16/2016 01:40 PM] (38) |
| Feb 9, 2016 | 71 | Entry of appearance for Aron Fischer as of counsel for Not party Janssen Biotech, Inc.. Service: 02/09/2016 by email. [309690] [Aron Fischer] [Entered: 02/09/2016 12:46 PM] (2) |
| Feb 8, 2016 | 68 | 6 paper copies of the Response Brief [67] received from Appellees Amgen Inc. and Amgen Manufacturing Limited. [309234] [MJL] [Entered: 02/08/2016 11:20 AM] (0) |
| Feb 8, 2016 | 69 | Entry of appearance for Gregory L. Diskant as principal counsel for Not party Janssen Biotech, Inc.. Service: 02/08/2016 by email. [309446] [Gregory Diskant] [Entered: 02/08/2016 05:38 PM] (2) |
| Feb 8, 2016 | 70 | Entry of appearance for Irena Royzman as of counsel for Not party Janssen Biotech, Inc.. Service: 02/08/2016 by email. [309450] [Irena Royzman] [Entered: 02/08/2016 05:41 PM] (2) |
| Feb 4, 2016 | 66 | TENDERED from Appellees Amgen Inc. and Amgen Manufacturing Limited. Title: RESPONSE BRIEF. Service: 02/04/2016 by email. [308669] [Nicholas Groombridge] [Entered: 02/04/2016 04:37 PM] (67) |
| Feb 4, 2016 | 67 | BRIEF FILED for Appellees Amgen Inc. and Amgen Manufacturing Limited [66]. Number of Pages: 58. Service: 02/04/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 02/10/2016. Appellants Apotex Corp. and Apotex Inc. reply brief is due 02/12/2016. [308855] [LN] [Entered: 02/05/2016 12:07 PM] (67) |
| Jan 27, 2016 | 63 | Entry of appearance for Jennifer H. Wu as of counsel for Appellees Amgen Inc. and Amgen Manufacturing Limited. Service: 01/27/2016 by email. [306040] [Nicholas Groombridge] [Entered: 01/27/2016 01:05 PM] (2) |
| Jan 27, 2016 | 64 | Amended Certificate of Interest for the Appellees Amgen Inc. and Amgen Manufacturing Limited. Service: 01/27/2016 by email. [306042] [Nicholas Groombridge] [Entered: 01/27/2016 01:07 PM] (2) |
| Jan 27, 2016 | 65 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Amgen Inc. and Amgen Manufacturing Limited. Service: 01/27/2016 by email. [306053] [Nicholas Groombridge] [Entered: 01/27/2016 01:19 PM] (3) |
| Jan 26, 2016 | 62 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Apotex Corp. and Apotex Inc.. Service: 01/25/2016 by email. [305592] [Kerry McTigue] [Entered: 01/25/2016 11:57 AM] (3) |
| Jan 8, 2016 | 60 | 6 paper copies of the Amicus Brief [54] received from Amicus Curiae Mylan Inc.. [301323] [MJL] [Entered: 01/08/2016 11:20 AM] (0) |
| Jan 8, 2016 | 61 | 6 paper copies of the Amicus Brief [55] received from Amici Curiae Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc.. [301419] [MJL] [Entered: 01/08/2016 02:45 PM] (0) |
| Jan 7, 2016 | 56 | Clerk's Note to the File: The Certificate of Interest for Amicus Curiae Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc. is due on 01/21/2016. [300996] [JCA] [Entered: 01/07/2016 09:50 AM] (0) |
| Jan 7, 2016 | 57 | Certificate of Interest for the Amicus Curiae Mylan Inc.. Service: 01/07/2016 by email. [301010] [William Rakoczy] [Entered: 01/07/2016 10:14 AM] (5) |
| Jan 7, 2016 | 58 | Certificate of Interest for the Amicus Curiae Biosimilars Council. Service: 01/07/2016 by email. [301066] [Carlos Angulo] [Entered: 01/07/2016 11:55 AM] (2) |
| Jan 7, 2016 | 59 | Certificate of Interest for the Amici Curiae Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc.. Service: 01/07/2016 by email. [301205] [Charles Klein] [Entered: 01/07/2016 05:43 PM] (6) |
| Jan 6, 2016 | 39 | 6 paper copies of the Opening Brief [38] received from Appellants Apotex Corp. and Apotex Inc.. [300625] [MJL] [Entered: 01/06/2016 09:23 AM] (0) |
| Jan 6, 2016 | 40 | Entry of appearance for Carlos T. Angulo as principal counsel for The Biosimilars Council. Service: 01/06/2016 by email. [300757] [Carlos Angulo] [Entered: 01/06/2016 12:44 PM] (4) |
| Jan 6, 2016 | 41 | TENDERED from Biosimilars Council Title: AMICUS CURIAE BRIEF. Service: 01/06/2016 by email. [300773] [Carlos Angulo] [Entered: 01/06/2016 01:14 PM] (33) |
| Jan 6, 2016 | 42 | AMICUS BRIEF FILED for Biosimilars Council [41]. Number of Pages: 24. Service: 01/06/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 01/11/2016. [300870] [JCA] [Entered: 01/06/2016 03:09 PM] (33) |
| Jan 6, 2016 | 43 | Clerk's Note to the File: The Certificate of Interest for Amicus Curiae Biosimilars Council is due on 01/20/2016. [300872] [JCA] [Entered: 01/06/2016 03:13 PM] (0) |
| Jan 6, 2016 | 44 | 6 paper copies of the Amicus Brief [42] received from Amicus Curiae Biosimilars Council. [300907] [MJL] [Entered: 01/06/2016 04:14 PM] (0) |
| Jan 6, 2016 | 45 | Entry of appearance for Charles B. Klein as principal counsel for Hospira, Inc., Celltrion Healthcare Co., Ltd. and Celltrion, Inc.. Service: 01/06/2016 by email. [300924] [Charles Klein] [Entered: 01/06/2016 05:08 PM] (4) |
| Jan 6, 2016 | 46 | Entry of appearance for Steffen N. Johnson as of counsel for Hospira, Inc., Celltrion Healthcare Co., Ltd., Celltrion, Inc.. Service: 01/06/2016 by email. [300925] [Steffen Johnson] [Entered: 01/06/2016 05:12 PM] (4) |
| Jan 6, 2016 | 47 | Entry of appearance for Samuel S. Park as of counsel for Hospira, Inc., Celltrion Healthcare Co., Ltd., and Celltrion, Inc.. Service: 01/06/2016 by email. [300927] [Samuel Park] [Entered: 01/06/2016 05:17 PM] (4) |
| Jan 6, 2016 | 48 | Entry of appearance for Dan H. Hoang as of counsel for Hospira, Inc., Celltrion Healthcare Co., Ltd., Celltrion, Inc.. Service: 01/06/2016 by email. [300928] [Dan Hoang] [Entered: 01/06/2016 05:18 PM] (4) |
| Jan 6, 2016 | 49 | Entry of appearance for Andrew C. Nichols as of counsel for Hospira, Inc., Celltrion Healthcare Co., Ltd., Celltrion, Inc.. Service: 01/06/2016 by email. [300929] [Andrew Nichols] [Entered: 01/06/2016 05:18 PM] (4) |
| Jan 6, 2016 | 50 | TENDERED from Hospira, Inc., Celltrion Healthcare, Co., Ltd., and Celltrion, Inc. Title: AMICUS CURIAE BRIEF. Service: 01/06/2016 by email. [300936] [Charles Klein] [Entered: 01/06/2016 05:41 PM] (37) |
| Jan 6, 2016 | 51 | Entry of appearance for William A. Rakoczy as principal counsel for Mylan Inc.. Service: 01/06/2016 by email. [300942] [William Rakoczy] [Entered: 01/06/2016 06:14 PM] (5) |
| Jan 6, 2016 | 52 | Entry of appearance for Lara E. FitzSimmons as of counsel for Mylan Inc.. Service: 01/06/2016 by email. [300943] [William Rakoczy] [Entered: 01/06/2016 06:15 PM] (5) |
| Jan 6, 2016 | 53 | TENDERED from Mylan Inc. Title: AMICUS CURIAE BRIEF. Service: 01/06/2016 by email. [300945] [William Rakoczy] [Entered: 01/06/2016 06:17 PM] (34) |
| Jan 6, 2016 | 54 | AMICUS BRIEF FILED for Mylan Inc. [53]. Number of Pages: 22. Service: 01/06/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 01/12/2016. [300993] [JCA] [Entered: 01/07/2016 09:47 AM] (34) |
| Jan 6, 2016 | 55 | AMICUS BRIEF FILED for Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira, Inc. [50]. Number of Pages: 25. Service: 01/06/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 01/12/2016. [300995] [JCA] [Entered: 01/07/2016 09:48 AM] (37) |
| Jan 4, 2016 | 36 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Brief Docket No. [35], ERROR: Miles J. Sweet is listed on the cover page of the brief as one of the attorneys for Apotex Inc. and Apotex Corp. CORRECTION: Mr. Sweet needs to file an entry of appearance if he intends on participating in this case. [299765] [JCA] [Entered: 01/04/2016 09:47 AM] (0) |
| Jan 4, 2016 | 37 | Entry of appearance for Miles J. Sweet as of counsel for Appellants Apotex Corp. and Apotex Inc.. Service: 01/04/2016 by email. [299863] [Miles Sweet] [Entered: 01/04/2016 12:09 PM] (2) |
| Dec 30, 2015 | 32 | ORDER filed granting motion to expedite briefing schedule [9], [11], [12] to the extent that Amgen’s response brief is due no later than February 4, 2016 and Apotex’s reply brief and the joint appendix are due no later than February 12, 2016.; The case will be placed on the next available oral argument calendar. - FOR CALENDAR; Service: 12/30/2015 by clerk. [299516] [NL] [Entered: 12/30/2015 04:29 PM] (2) |
| Dec 30, 2015 | 33 | Entry of appearance for John Christopher Rozendaal as of counsel for Appellants Apotex Corp. and Apotex Inc.. Service: 12/30/2015 by email. [299528] [John Rozendaal] [Entered: 12/30/2015 04:42 PM] (2) |
| Dec 30, 2015 | 34 | Entry of appearance for David C. Frederick as of counsel for Appellants Apotex Corp. and Apotex Inc.. Service: 12/30/2015 by email. [299534] [David Frederick] [Entered: 12/30/2015 04:56 PM] (2) |
| Dec 30, 2015 | 35 | TENDERED from Appellants Apotex Corp. and Apotex Inc.. Title: OPENING BRIEF. Service: 12/30/2015 by email. [299537] [Kerry McTigue] [Entered: 12/30/2015 05:03 PM] (58) |
| Dec 30, 2015 | 38 | BRIEF FILED for Appellants Apotex Corp. and Apotex Inc. [35]. Number of Pages: 37. Service: 12/30/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 01/11/2016. [299968] [JCA] [Entered: 01/04/2016 02:20 PM] (58) |
| Dec 28, 2015 | 30 | Docketing Statement for the Appellees Amgen Inc. and Amgen Manufacturing Limited. Service: 12/24/2015 by email. [298702] [Nicholas Groombridge] [Entered: 12/24/2015 11:29 AM] (4) |
| Dec 28, 2015 | 31 | Docketing Statement for the Appellants Apotex Corp. and Apotex Inc.. Service: 12/28/2015 by email. [298972] [Kerry McTigue] [Entered: 12/28/2015 04:24 PM] (4) |
| Dec 23, 2015 | 26 | Entry of appearance for John F. O'Sullivan as of counsel for Appellees Amgen Inc. and Amgen Manufacturing Limited. Service: 12/23/2015 by email. [298410] [John O'Sullivan] [Entered: 12/23/2015 10:24 AM] (2) |
| Dec 23, 2015 | 27 | Entry of appearance for Allen P. Pegg as of counsel for Appellees Amgen Inc. and Amgen Manufacturing Limited. Service: 12/23/2015 by email. [298413] [Allen Pegg] [Entered: 12/23/2015 10:28 AM] (2) |
| Dec 23, 2015 | 28 | Entry of appearance for Jason D. Sternberg as of counsel for Appellees Amgen Inc. and Amgen Manufacturing Limited. Service: 12/23/2015 by email. [298417] [Jason Sternberg] [Entered: 12/23/2015 10:32 AM] (2) |
| Dec 23, 2015 | 29 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entries of appearance Docket No. [28], [27], and [26], ERROR: The entries of appearance were not text searchable as required by ECF-7(B). CORRECTION: No further action is required. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [298593] [IW] [Entered: 12/23/2015 03:08 PM] (0) |
| Dec 22, 2015 | 25 | REPLY of Appellants Apotex Corp. and Apotex Inc. to response filed by Appellees in 16-1308 , Doc. No [24]. Service: 12/22/2015 by email. [298190] [Kerry McTigue] [Entered: 12/22/2015 01:58 PM] (7) |
| Dec 18, 2015 | 23 | RESPONSE of Appellees Amgen Inc. and Amgen Manufacturing Limited to the motion to expedite briefing schedule [12] filed by Appellants Apotex Inc. and Apotex Corp. in 16-1308 , motion to expedite briefing schedule [11] filed by Appellants Apotex Inc. and Apotex Corp. in 16-1308 , motion to expedite briefing schedule [9] with MOTION to to expedite case. Response/Opposition is due 12/31/2015 Service: 12/18/2015 by email [297598]--[Edited 12/18/2015 by clerk. No motion is incorporated with this response. Filer used the wrong event to submit the response. No action is needed on this response as the document was refiled (see entry #24).] [Nicholas Groombridge] [Entered: 12/18/2015 03:48 PM] (11) |
| Dec 18, 2015 | 24 | RESPONSE of Appellees Amgen Inc. and Amgen Manufacturing Limited to the motion to expedite briefing schedule [12] filed by Appellants Apotex Inc. and Apotex Corp. in 16-1308 , motion to expedite briefing schedule [11] filed by Appellants Apotex Inc. and Apotex Corp. in 16-1308 , motion to expedite briefing schedule [9]. Service: 12/18/2015 by email. [297608] [Nicholas Groombridge] [Entered: 12/18/2015 03:57 PM] (11) |
| Dec 17, 2015 | 14 | Entry of appearance for Nicholas Groombridge as principal counsel for Appellees Amgen Inc. and Amgen Manufacturing Limited. Service: 12/17/2015 by email. [297119] [Nicholas Groombridge] [Entered: 12/17/2015 12:24 PM] (2) |
| Dec 17, 2015 | 15 | Entry of appearance for Eric Alan Stone as of counsel for Appellees Amgen Inc. and Amgen Manufacturing Limited. Service: 12/17/2015 by email. [297120] [Nicholas Groombridge] [Entered: 12/17/2015 12:27 PM] (2) |
| Dec 17, 2015 | 16 | Entry of appearance for Catherine Nyarady as of counsel for Appellees Amgen Inc. and Amgen Manufacturing Limited. Service: 12/17/2015 by email. [297121] [Nicholas Groombridge] [Entered: 12/17/2015 12:31 PM] (2) |
| Dec 17, 2015 | 17 | Entry of appearance for Jennifer Gordon as of counsel for Appellees Amgen Inc. and Amgen Manufacturing Limited. Service: 12/17/2015 by email. [297122] [Nicholas Groombridge] [Entered: 12/17/2015 12:34 PM] (2) |
| Dec 17, 2015 | 18 | Entry of appearance for Peter Sandel as of counsel for Appellees Amgen Inc. and Amgen Manufacturing Limited. Service: 12/17/2015 by email. [297124] [Nicholas Groombridge] [Entered: 12/17/2015 12:35 PM] (2) |
| Dec 17, 2015 | 19 | Entry of appearance for Wendy A. Whiteford as of counsel for Appellees Amgen Inc. and Amgen Manufacturing Limited. Service: 12/17/2015 by email. [297125] [Nicholas Groombridge] [Entered: 12/17/2015 12:37 PM] (2) |
| Dec 17, 2015 | 20 | Entry of appearance for Lois M. Kwasigroch as of counsel for Appellees Amgen Inc. and Amgen Manufacturing Limited. Service: 12/17/2015 by email. [297127] [Nicholas Groombridge] [Entered: 12/17/2015 12:38 PM] (2) |
| Dec 17, 2015 | 21 | Entry of appearance for Kimberlin L. Morley as of counsel for Appellees Amgen Inc. and Amgen Manufacturing Limited. Service: 12/17/2015 by email. [297129] [Nicholas Groombridge] [Entered: 12/17/2015 12:40 PM] (2) |
| Dec 17, 2015 | 22 | Certificate of Interest for the Appellees Amgen Inc. and Amgen Manufacturing Limited. Service: 12/17/2015 by email. [297131] [Nicholas Groombridge] [Entered: 12/17/2015 12:43 PM] (2) |
| Dec 15, 2015 | 10 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a), Fed. Cir. R. 47.3 and ECF-2(E) to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. EOA information does not match ECF filer information for attorneys William Blake Coblentz and Donald R. McPhail. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [296201] [JAB] [Entered: 12/15/2015 09:45 AM] (0) |
| Dec 15, 2015 | 11 | MOTION of Appellants Apotex Corp. and Apotex Inc. to expedite briefing schedule. Response/Opposition is due 12/31/2015 [Consent: opposed]. Service: 12/15/2015 by email. [296240] [Kerry McTigue] [Entered: 12/15/2015 10:35 AM] (18) |
| Dec 15, 2015 | 12 | MOTION of Appellants Apotex Corp. and Apotex Inc. to expedite briefing schedule. Response/Opposition is due 12/31/2015 [Consent: opposed]. Service: 12/15/2015 by email. [296244] [Kerry McTigue] [Entered: 12/15/2015 10:43 AM] (18) |
| Dec 15, 2015 | 13 | ORDER filed. Amgen's opposition to the motion [9] [11] [12] is due no later than December 18, 2015. Any reply in support of the motion is due no later than December 22, 2015. Apotex's opening brief is due no later than December 30, 2015. Service: 12/15/2015 by clerk. [296297] [LMS] [Entered: 12/15/2015 11:40 AM] (2) |
| Dec 14, 2015 | 3 | Entry of appearance for Kerry B. McTigue as principal counsel for Appellants Apotex Corp. and Apotex Inc.. Service: 12/14/2015 by email. [295829] [Kerry McTigue] [Entered: 12/14/2015 02:09 PM] (2) |
| Dec 14, 2015 | 4 | Entry of appearance for Aaron S. Lukas as of counsel for Appellants Apotex Corp. and Apotex Inc.. Service: 12/14/2015 by email. [295842] [Kerry McTigue] [Entered: 12/14/2015 02:23 PM] (2) |
| Dec 14, 2015 | 5 | Entry of appearance for William Blake Coblentz as of counsel for Appellants Apotex Corp. and Apotex Inc.. Service: 12/14/2015 by email. [295844] [Kerry McTigue] [Entered: 12/14/2015 02:25 PM] (2) |
| Dec 14, 2015 | 6 | Entry of appearance for Barry P. Golob as of counsel for Appellants Apotex Corp. and Apotex Inc.. Service: 12/14/2015 by email. [295855] [Kerry McTigue] [Entered: 12/14/2015 02:43 PM] (2) |
| Dec 14, 2015 | 7 | Entry of appearance for Donald R. McPhail as of counsel for Appellants Apotex Corp. and Apotex Inc.. Service: 12/14/2015 by email. [295859] [Kerry McTigue] [Entered: 12/14/2015 02:45 PM] (2) |
| Dec 14, 2015 | 8 | Certificate of Interest for the Appellants Apotex Corp. and Apotex Inc.. Service: 12/14/2015 by email. [295869] [Kerry McTigue] [Entered: 12/14/2015 02:56 PM] (3) |
| Dec 14, 2015 | 9 | MOTION of to expedite briefing schedule. Response/Opposition is due 12/31/2015 [Consent: opposed]. Service: 12/14/2015 by email. [295882] [Kerry McTigue] [Entered: 12/14/2015 03:14 PM] (8) |
| Dec 11, 2015 | 1 | Appeal docketed. Received: 12/11/2015. [295450]Entry of Appearance due 12/28/2015. Certificate of Interest is due on 12/28/2015. Docketing Statement due 12/28/2015. Appellant/Petitioner's brief is due 02/09/2016. [LN] [Entered: 12/11/2015 11:37 AM] (40) |
| Dec 11, 2015 | 2 | Transcript Purchase Order Form for the Appellants Apotex Corp. and Apotex Inc. indicating that a transcript is already on file. Service: 12/11/2015 by email. [295688] [JCA] [Entered: 12/14/2015 10:05 AM] (1) |
